Point-of-care Molecular Diagnostic Solution Market, Global Outlook and Forecast 2022-2028

March 2022 | 60 pages | ID: P72F385F55A4EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Point-of-care Molecular Diagnostic Solution in Global, including the following market information:

Global Point-of-care Molecular Diagnostic Solution Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Point-of-care Molecular Diagnostic Solution market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Assays & kits Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Point-of-care Molecular Diagnostic Solution include Abbott Laboratories, F. Hoffmann-La Roche AG, Becton, Dickinson and Company, BioMerieux, Bio-Rad Laboratories, Inc., Cepheid, Inc., Danaher Corporation, Johnson and Johnson and Bayer Healthcare. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Point-of-care Molecular Diagnostic Solution companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Point-of-care Molecular Diagnostic Solution Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Point-of-care Molecular Diagnostic Solution Market Segment Percentages, by Type, 2021 (%)

• Assays & kits
• Instruments & Analyzers
• Software & Services

Global Point-of-care Molecular Diagnostic Solution Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Point-of-care Molecular Diagnostic Solution Market Segment Percentages, by Application, 2021 (%)

• Physicians’ Offices
• Hospitals & ICUs
• Research Institutes
• Other End Users

Global Point-of-care Molecular Diagnostic Solution Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Point-of-care Molecular Diagnostic Solution Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Point-of-care Molecular Diagnostic Solution revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Point-of-care Molecular Diagnostic Solution revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abbott Laboratories
• F. Hoffmann-La Roche AG
• Becton, Dickinson and Company
• BioMerieux
• Bio-Rad Laboratories, Inc.
• Cepheid, Inc.
• Danaher Corporation
• Johnson and Johnson
• Bayer Healthcare

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Point-of-care Molecular Diagnostic Solution Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Point-of-care Molecular Diagnostic Solution Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTIC SOLUTION OVERALL MARKET SIZE

2.1 Global Point-of-care Molecular Diagnostic Solution Market Size: 2021 VS 2028
2.2 Global Point-of-care Molecular Diagnostic Solution Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Point-of-care Molecular Diagnostic Solution Players in Global Market
3.2 Top Global Point-of-care Molecular Diagnostic Solution Companies Ranked by Revenue
3.3 Global Point-of-care Molecular Diagnostic Solution Revenue by Companies
3.4 Top 3 and Top 5 Point-of-care Molecular Diagnostic Solution Companies in Global Market, by Revenue in 2021
3.5 Global Companies Point-of-care Molecular Diagnostic Solution Product Type
3.6 Tier 1, Tier 2 and Tier 3 Point-of-care Molecular Diagnostic Solution Players in Global Market
  3.6.1 List of Global Tier 1 Point-of-care Molecular Diagnostic Solution Companies
  3.6.2 List of Global Tier 2 and Tier 3 Point-of-care Molecular Diagnostic Solution Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Point-of-care Molecular Diagnostic Solution Market Size Markets, 2021 & 2028
  4.1.2 Assays & kits
  4.1.3 Instruments & Analyzers
  4.1.4 Software & Services
4.2 By Type - Global Point-of-care Molecular Diagnostic Solution Revenue & Forecasts
  4.2.1 By Type - Global Point-of-care Molecular Diagnostic Solution Revenue, 2017-2022
  4.2.2 By Type - Global Point-of-care Molecular Diagnostic Solution Revenue, 2023-2028
  4.2.3 By Type - Global Point-of-care Molecular Diagnostic Solution Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Point-of-care Molecular Diagnostic Solution Market Size, 2021 & 2028
  5.1.2 Physicians’ Offices
  5.1.3 Hospitals & ICUs
  5.1.4 Research Institutes
  5.1.5 Other End Users
5.2 By Application - Global Point-of-care Molecular Diagnostic Solution Revenue & Forecasts
  5.2.1 By Application - Global Point-of-care Molecular Diagnostic Solution Revenue, 2017-2022
  5.2.2 By Application - Global Point-of-care Molecular Diagnostic Solution Revenue, 2023-2028
  5.2.3 By Application - Global Point-of-care Molecular Diagnostic Solution Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Point-of-care Molecular Diagnostic Solution Market Size, 2021 & 2028
6.2 By Region - Global Point-of-care Molecular Diagnostic Solution Revenue & Forecasts
  6.2.1 By Region - Global Point-of-care Molecular Diagnostic Solution Revenue, 2017-2022
  6.2.2 By Region - Global Point-of-care Molecular Diagnostic Solution Revenue, 2023-2028
  6.2.3 By Region - Global Point-of-care Molecular Diagnostic Solution Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Point-of-care Molecular Diagnostic Solution Revenue, 2017-2028
  6.3.2 US Point-of-care Molecular Diagnostic Solution Market Size, 2017-2028
  6.3.3 Canada Point-of-care Molecular Diagnostic Solution Market Size, 2017-2028
  6.3.4 Mexico Point-of-care Molecular Diagnostic Solution Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Point-of-care Molecular Diagnostic Solution Revenue, 2017-2028
  6.4.2 Germany Point-of-care Molecular Diagnostic Solution Market Size, 2017-2028
  6.4.3 France Point-of-care Molecular Diagnostic Solution Market Size, 2017-2028
  6.4.4 U.K. Point-of-care Molecular Diagnostic Solution Market Size, 2017-2028
  6.4.5 Italy Point-of-care Molecular Diagnostic Solution Market Size, 2017-2028
  6.4.6 Russia Point-of-care Molecular Diagnostic Solution Market Size, 2017-2028
  6.4.7 Nordic Countries Point-of-care Molecular Diagnostic Solution Market Size, 2017-2028
  6.4.8 Benelux Point-of-care Molecular Diagnostic Solution Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Point-of-care Molecular Diagnostic Solution Revenue, 2017-2028
  6.5.2 China Point-of-care Molecular Diagnostic Solution Market Size, 2017-2028
  6.5.3 Japan Point-of-care Molecular Diagnostic Solution Market Size, 2017-2028
  6.5.4 South Korea Point-of-care Molecular Diagnostic Solution Market Size, 2017-2028
  6.5.5 Southeast Asia Point-of-care Molecular Diagnostic Solution Market Size, 2017-2028
  6.5.6 India Point-of-care Molecular Diagnostic Solution Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Point-of-care Molecular Diagnostic Solution Revenue, 2017-2028
  6.6.2 Brazil Point-of-care Molecular Diagnostic Solution Market Size, 2017-2028
  6.6.3 Argentina Point-of-care Molecular Diagnostic Solution Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Point-of-care Molecular Diagnostic Solution Revenue, 2017-2028
  6.7.2 Turkey Point-of-care Molecular Diagnostic Solution Market Size, 2017-2028
  6.7.3 Israel Point-of-care Molecular Diagnostic Solution Market Size, 2017-2028
  6.7.4 Saudi Arabia Point-of-care Molecular Diagnostic Solution Market Size, 2017-2028
  6.7.5 UAE Point-of-care Molecular Diagnostic Solution Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Abbott Laboratories
  7.1.1 Abbott Laboratories Corporate Summary
  7.1.2 Abbott Laboratories Business Overview
  7.1.3 Abbott Laboratories Point-of-care Molecular Diagnostic Solution Major Product Offerings
  7.1.4 Abbott Laboratories Point-of-care Molecular Diagnostic Solution Revenue in Global Market (2017-2022)
  7.1.5 Abbott Laboratories Key News
7.2 F. Hoffmann-La Roche AG
  7.2.1 F. Hoffmann-La Roche AG Corporate Summary
  7.2.2 F. Hoffmann-La Roche AG Business Overview
  7.2.3 F. Hoffmann-La Roche AG Point-of-care Molecular Diagnostic Solution Major Product Offerings
  7.2.4 F. Hoffmann-La Roche AG Point-of-care Molecular Diagnostic Solution Revenue in Global Market (2017-2022)
  7.2.5 F. Hoffmann-La Roche AG Key News
7.3 Becton, Dickinson and Company
  7.3.1 Becton, Dickinson and Company Corporate Summary
  7.3.2 Becton, Dickinson and Company Business Overview
  7.3.3 Becton, Dickinson and Company Point-of-care Molecular Diagnostic Solution Major Product Offerings
  7.3.4 Becton, Dickinson and Company Point-of-care Molecular Diagnostic Solution Revenue in Global Market (2017-2022)
  7.3.5 Becton, Dickinson and Company Key News
7.4 BioMerieux
  7.4.1 BioMerieux Corporate Summary
  7.4.2 BioMerieux Business Overview
  7.4.3 BioMerieux Point-of-care Molecular Diagnostic Solution Major Product Offerings
  7.4.4 BioMerieux Point-of-care Molecular Diagnostic Solution Revenue in Global Market (2017-2022)
  7.4.5 BioMerieux Key News
7.5 Bio-Rad Laboratories, Inc.
  7.5.1 Bio-Rad Laboratories, Inc. Corporate Summary
  7.5.2 Bio-Rad Laboratories, Inc. Business Overview
  7.5.3 Bio-Rad Laboratories, Inc. Point-of-care Molecular Diagnostic Solution Major Product Offerings
  7.5.4 Bio-Rad Laboratories, Inc. Point-of-care Molecular Diagnostic Solution Revenue in Global Market (2017-2022)
  7.5.5 Bio-Rad Laboratories, Inc. Key News
7.6 Cepheid, Inc.
  7.6.1 Cepheid, Inc. Corporate Summary
  7.6.2 Cepheid, Inc. Business Overview
  7.6.3 Cepheid, Inc. Point-of-care Molecular Diagnostic Solution Major Product Offerings
  7.6.4 Cepheid, Inc. Point-of-care Molecular Diagnostic Solution Revenue in Global Market (2017-2022)
  7.6.5 Cepheid, Inc. Key News
7.7 Danaher Corporation
  7.7.1 Danaher Corporation Corporate Summary
  7.7.2 Danaher Corporation Business Overview
  7.7.3 Danaher Corporation Point-of-care Molecular Diagnostic Solution Major Product Offerings
  7.7.4 Danaher Corporation Point-of-care Molecular Diagnostic Solution Revenue in Global Market (2017-2022)
  7.7.5 Danaher Corporation Key News
7.8 Johnson and Johnson
  7.8.1 Johnson and Johnson Corporate Summary
  7.8.2 Johnson and Johnson Business Overview
  7.8.3 Johnson and Johnson Point-of-care Molecular Diagnostic Solution Major Product Offerings
  7.8.4 Johnson and Johnson Point-of-care Molecular Diagnostic Solution Revenue in Global Market (2017-2022)
  7.8.5 Johnson and Johnson Key News
7.9 Bayer Healthcare
  7.9.1 Bayer Healthcare Corporate Summary
  7.9.2 Bayer Healthcare Business Overview
  7.9.3 Bayer Healthcare Point-of-care Molecular Diagnostic Solution Major Product Offerings
  7.9.4 Bayer Healthcare Point-of-care Molecular Diagnostic Solution Revenue in Global Market (2017-2022)
  7.9.5 Bayer Healthcare Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Point-of-care Molecular Diagnostic Solution Market Opportunities & Trends in Global Market
Table 2. Point-of-care Molecular Diagnostic Solution Market Drivers in Global Market
Table 3. Point-of-care Molecular Diagnostic Solution Market Restraints in Global Market
Table 4. Key Players of Point-of-care Molecular Diagnostic Solution in Global Market
Table 5. Top Point-of-care Molecular Diagnostic Solution Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Point-of-care Molecular Diagnostic Solution Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Point-of-care Molecular Diagnostic Solution Revenue Share by Companies, 2017-2022
Table 8. Global Companies Point-of-care Molecular Diagnostic Solution Product Type
Table 9. List of Global Tier 1 Point-of-care Molecular Diagnostic Solution Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Point-of-care Molecular Diagnostic Solution Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Point-of-care Molecular Diagnostic Solution Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Point-of-care Molecular Diagnostic Solution Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Point-of-care Molecular Diagnostic Solution Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Point-of-care Molecular Diagnostic Solution Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Point-of-care Molecular Diagnostic Solution Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Point-of-care Molecular Diagnostic Solution Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Point-of-care Molecular Diagnostic Solution Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Point-of-care Molecular Diagnostic Solution Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Point-of-care Molecular Diagnostic Solution Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Point-of-care Molecular Diagnostic Solution Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Point-of-care Molecular Diagnostic Solution Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Point-of-care Molecular Diagnostic Solution Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Point-of-care Molecular Diagnostic Solution Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Point-of-care Molecular Diagnostic Solution Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Point-of-care Molecular Diagnostic Solution Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Point-of-care Molecular Diagnostic Solution Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Point-of-care Molecular Diagnostic Solution Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Point-of-care Molecular Diagnostic Solution Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Point-of-care Molecular Diagnostic Solution Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Laboratories Corporate Summary
Table 31. Abbott Laboratories Point-of-care Molecular Diagnostic Solution Product Offerings
Table 32. Abbott Laboratories Point-of-care Molecular Diagnostic Solution Revenue (US$, Mn), (2017-2022)
Table 33. F. Hoffmann-La Roche AG Corporate Summary
Table 34. F. Hoffmann-La Roche AG Point-of-care Molecular Diagnostic Solution Product Offerings
Table 35. F. Hoffmann-La Roche AG Point-of-care Molecular Diagnostic Solution Revenue (US$, Mn), (2017-2022)
Table 36. Becton, Dickinson and Company Corporate Summary
Table 37. Becton, Dickinson and Company Point-of-care Molecular Diagnostic Solution Product Offerings
Table 38. Becton, Dickinson and Company Point-of-care Molecular Diagnostic Solution Revenue (US$, Mn), (2017-2022)
Table 39. BioMerieux Corporate Summary
Table 40. BioMerieux Point-of-care Molecular Diagnostic Solution Product Offerings
Table 41. BioMerieux Point-of-care Molecular Diagnostic Solution Revenue (US$, Mn), (2017-2022)
Table 42. Bio-Rad Laboratories, Inc. Corporate Summary
Table 43. Bio-Rad Laboratories, Inc. Point-of-care Molecular Diagnostic Solution Product Offerings
Table 44. Bio-Rad Laboratories, Inc. Point-of-care Molecular Diagnostic Solution Revenue (US$, Mn), (2017-2022)
Table 45. Cepheid, Inc. Corporate Summary
Table 46. Cepheid, Inc. Point-of-care Molecular Diagnostic Solution Product Offerings
Table 47. Cepheid, Inc. Point-of-care Molecular Diagnostic Solution Revenue (US$, Mn), (2017-2022)
Table 48. Danaher Corporation Corporate Summary
Table 49. Danaher Corporation Point-of-care Molecular Diagnostic Solution Product Offerings
Table 50. Danaher Corporation Point-of-care Molecular Diagnostic Solution Revenue (US$, Mn), (2017-2022)
Table 51. Johnson and Johnson Corporate Summary
Table 52. Johnson and Johnson Point-of-care Molecular Diagnostic Solution Product Offerings
Table 53. Johnson and Johnson Point-of-care Molecular Diagnostic Solution Revenue (US$, Mn), (2017-2022)
Table 54. Bayer Healthcare Corporate Summary
Table 55. Bayer Healthcare Point-of-care Molecular Diagnostic Solution Product Offerings
Table 56. Bayer Healthcare Point-of-care Molecular Diagnostic Solution Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Point-of-care Molecular Diagnostic Solution Segment by Type in 2021
Figure 2. Point-of-care Molecular Diagnostic Solution Segment by Application in 2021
Figure 3. Global Point-of-care Molecular Diagnostic Solution Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Point-of-care Molecular Diagnostic Solution Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Point-of-care Molecular Diagnostic Solution Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Point-of-care Molecular Diagnostic Solution Revenue in 2021
Figure 8. By Type - Global Point-of-care Molecular Diagnostic Solution Revenue Market Share, 2017-2028
Figure 9. By Application - Global Point-of-care Molecular Diagnostic Solution Revenue Market Share, 2017-2028
Figure 10. By Region - Global Point-of-care Molecular Diagnostic Solution Revenue Market Share, 2017-2028
Figure 11. By Country - North America Point-of-care Molecular Diagnostic Solution Revenue Market Share, 2017-2028
Figure 12. US Point-of-care Molecular Diagnostic Solution Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Point-of-care Molecular Diagnostic Solution Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Point-of-care Molecular Diagnostic Solution Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Point-of-care Molecular Diagnostic Solution Revenue Market Share, 2017-2028
Figure 16. Germany Point-of-care Molecular Diagnostic Solution Revenue, (US$, Mn), 2017-2028
Figure 17. France Point-of-care Molecular Diagnostic Solution Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Point-of-care Molecular Diagnostic Solution Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Point-of-care Molecular Diagnostic Solution Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Point-of-care Molecular Diagnostic Solution Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Point-of-care Molecular Diagnostic Solution Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Point-of-care Molecular Diagnostic Solution Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Point-of-care Molecular Diagnostic Solution Revenue Market Share, 2017-2028
Figure 24. China Point-of-care Molecular Diagnostic Solution Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Point-of-care Molecular Diagnostic Solution Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Point-of-care Molecular Diagnostic Solution Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Point-of-care Molecular Diagnostic Solution Revenue, (US$, Mn), 2017-2028
Figure 28. India Point-of-care Molecular Diagnostic Solution Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Point-of-care Molecular Diagnostic Solution Revenue Market Share, 2017-2028
Figure 30. Brazil Point-of-care Molecular Diagnostic Solution Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Point-of-care Molecular Diagnostic Solution Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Point-of-care Molecular Diagnostic Solution Revenue Market Share, 2017-2028
Figure 33. Turkey Point-of-care Molecular Diagnostic Solution Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Point-of-care Molecular Diagnostic Solution Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Point-of-care Molecular Diagnostic Solution Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Point-of-care Molecular Diagnostic Solution Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Laboratories Point-of-care Molecular Diagnostic Solution Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. F. Hoffmann-La Roche AG Point-of-care Molecular Diagnostic Solution Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Becton, Dickinson and Company Point-of-care Molecular Diagnostic Solution Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. BioMerieux Point-of-care Molecular Diagnostic Solution Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Bio-Rad Laboratories, Inc. Point-of-care Molecular Diagnostic Solution Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Cepheid, Inc. Point-of-care Molecular Diagnostic Solution Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Danaher Corporation Point-of-care Molecular Diagnostic Solution Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Johnson and Johnson Point-of-care Molecular Diagnostic Solution Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Bayer Healthcare Point-of-care Molecular Diagnostic Solution Revenue Year Over Year Growth (US$, Mn) & (2017-2022)